Michigan Medicine

1500 E. Medical Center Drive, Ann Arbor, Michigan 48109

Michigan Medicine, affiliated with the University of Michigan, is one of the best mesothelioma cancer centers in the United States. The hospital features an innovative approach to treating malignant mesothelioma.

Michigan Medicine
Speciality Icon

Pleural Mesothelioma

Location icon

Michigan Medicine

1500 E. Medical Center Drive

Ann Arbor, Michigan

Dr. Gregory Kalemkerian


JUMP TO A TOPIC

jump to icon

SCROLL TO TOP

More About Mesothelioma Treatment at Michigan Medicine

Michigan Medicine provides a highly trained program for people diagnosed with mesothelioma cancer. With a high-profile addition to its staff, Michigan Medicine launched its pleural mesothelioma program in 2019. The facility added Dr. Elliot Wakeam, a thoracic surgeon trained at Princess Margaret Cancer Centre in Toronto. He left Michigan Medicine in 2022 to re-join Toronto General Hospital.

Dr. Wakeam brought more than a decade of experience working with mesothelioma patients. He brought with him an innovative treatment protocol, which utilizes radiation in tandem with surgery.

“There are several advantages to SMART,” Dr. Wakeam said in a phone interview with Mesothelioma Guide. “The problem with surgery is you’ll get a local recurrence. … That’s where the radiation is key.”

Michigan Medicine’s launch of a mesothelioma program is a huge boost for people living in the upper-midwest region. Patients get treated at the Rogel Cancer Center, part of Michigan Medicine. Rogel Cancer Center is a National Cancer Institute-designated institution. It’s one of just two with this prestigious label in the state of Michigan.

Most of the top mesothelioma cancer centers are along the eastern and western coastlines. Now people living in Michigan, Ohio and Indiana have a new option for treatment without traveling thousands of miles.

Cancer Center Specialists Icon

Experienced Mesothelioma Specialists

    • Dr. Gregory Kalemkerian, medical oncologist
Cancer Center Affiliations Icon

Affiliations

    • University of Michigan
    • Rogel Cancer Center
Cancer Center Treatments Icon

Treatment Specialties

    • SMART for pleural mesothelioma
    • Radiation therapy
    • Extrapleural pneumonectomy surgery
Get Connected to Michigan Medicine - Form Image

Get Connected to Michigan Medicine

Michigan Medicine is one of the latest hospitals to add a mesothelioma treatment program. The staff includes an esteemed thoracic surgeon who has developed a protocol for treating pleural mesothelioma.

Why Choose Michigan Medicine?

  • Innovative approach to treating mesothelioma
  • Led by a surgeon trained at Toronto’s top cancer center
  • Located in a U.S. region with few options for treatment






We value your privacy and will never sell or rent your personal information to any third party.

SMART for Mesothelioma

SMART for mesothelioma is Michigan Medicine’s groundbreaking protocol. SMART is an acronym for “surgery for mesothelioma after radiation therapy.” SMART utilizes “neoadjuvant” radiation, which is radiotherapy occurring before surgery.

SMART is for pleural mesothelioma. It was conceptualized at Princess Margaret Cancer Centre in Toronto.

“We use radiation to sterilize the margins (of the disease),” Dr. Wakeam said. “There are several advantages to SMART.”

The Michigan Medicine staff is open to SMART for patients with biphasic and sarcomatoid mesothelioma cell types. This allows more people to receive life-saving treatment.

What Is Part of SMART at Michigan Medicine?

Patients undergo five days of radiation therapy. Once the treatment step concludes, there’s a five-day pause to allow patients to recover. They then undergo surgery, either extrapleural pneumonectomy (EPP) or pleurectomy with decortication (P/D).

Following surgery, patients may receive further radiation or chemotherapy if needed. Dr. Wakeam and his staff are also looking into using mesothelioma immunotherapy with radiation.

Survival Rates of SMART for Mesothelioma

At the Princess Margaret Cancer Center, the SMART approach led to extraordinary results. For patients with the epithelioid cell type:

  • The median survival was 51 months
  • Around 72% survived for at least three years
Cancer Center Ranking Icon

Hospital Ranking

    • Not listed in the U.S. News & World Report 2024-2025 Hospitals Honor Roll
    • Ranked 34th in cancer treatment
    • Ranked 27th in gastrointestinal cancer surgery
    • Ranked 16th in lung cancer surgery
    • Ranked 1st in state of Michigan
    • Ranked 1st in Detroit

Experienced Staff

If you go to Michigan Medicine, there are many others involved with your medical care. They include a:

  • Medical oncologist
  • Radiation oncologist
  • Registered nurse and clinic coordinator, equivalent to a nurse navigator

They all play a role in creating a patient-first culture at Michigan Medicine. There is no set-in-stone approach to treating mesothelioma.

The patient advocates at Mesothelioma Guide have connections with the Michigan Medicine staff. Our team can help you set up an appointment to meet with these esteemed medical professionals. Contact one of our patient advocates at 1-888-385-2024 or fill out this form to have a team member contact you.

Sources & Author

  1. Gregory Peter Kalemkerian, MD. University of Michigan Health. Retrieved from: https://www.uofmhealth.org/profile/224/gregory-peter-kalemkerian-md. Accessed: 09/13/2021.
  2. University of Michigan Hospitals-Michigan Medicine. U.S. News & World Report. Retrieved from: https://health.usnews.com/best-hospitals/area/mi/university-of-michigan-hospitals-and-health-centers-6440110. Accessed: 07/25/2024.
Devin Golden

About the Writer, Devin Golden

Devin Golden is the senior content writer for Mesothelioma Guide. He produces mesothelioma-related content on various mediums, including the Mesothelioma Guide website and social media channels. Devin's objective is to translate complex information regarding mesothelioma into informative, easily absorbable content to help patients and their loved ones.